Search research articles
Contact Us
Filters
Showing results (211-220 of 226) with videos related to
Page
of 23
Sort By:
Dermatology Reports
|
April 17, 2025
Acral lentiginous melanoma with subsequent spontaneous vitiligo vulgaris: a case report and literature review
Ronak Saeed Ahmed, Rozhgar Rashid Ali, Dilan S Hiwa, et al.
Journal of Biomolecular Structure & Dynamics
|
March 6, 2025
Evaluation of cannabis-derived anti-inflammatory and analgesic treatment in animals and identification of cannabinoid-based effective inhibition of prostaglandin through computational studies
Hamna Rafiq, Ghulam Fareed, Hafiz Muzzammel Rehman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 3, 2018
Efficacy of Antitoxin Therapy in Treating Patients With Foodborne Botulism: A Systematic Review and Meta-analysis of Cases, 1923-2016
John C O'Horo, Eugene P Harper, Abdelghani El Rafei, et al.
Trials
|
November 3, 2020
Hyperimmune anti-COVID-19 IVIG (C-IVIG) Therapy for Passive Immunization of Severe and Critically Ill COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial
Shaukat Ali, Shobha Luxmi, Fatima Anjum, et al.
Nature Chemistry
|
November 24, 2017
Bicyclic Baird-type aromaticity
Won-Young Cha, Taeyeon Kim, Arindam Ghosh, et al.
International Journal of Molecular Sciences
|
August 12, 2022
The Genome of the Mimosoid Legume <i>Prosopis cineraria</i>, a Desert Tree
Naganeeswaran Sudalaimuthuasari, Rashid Ali, Martin Kottackal, et al.
Medicine
|
June 2, 2023
Knowledge, attitudes, and practices (KAP) during the malaria elimination phase: A household-based cross-sectional survey
Siddig Ibrahim Abdelwahab, Ibrahim M Elhassan, Osama Albasheer, et al.
Trials
|
November 9, 2022
Phase II/III trial of hyperimmune anti-COVID-19 intravenous immunoglobulin (C-IVIG) therapy in severe COVID-19 patients: study protocol for a randomized controlled trial
Shaukat Ali, Elisha Shalim, Farah Farhan, et al.
Eclinicalmedicine
|
June 10, 2021
Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial
Shaukat Ali, Syed Muneeb Uddin, Elisha Shalim, et al.
BMC Endocrine Disorders
|
October 22, 2025
Erectile dysfunction among diabetic patients in Western Uganda: prevalence and associated factors in a multicentre study across three selected clinics
Venance Emmanuel Mswelo, Afizi Kibuuka, Tijjani Salihu Shinkafi, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 226) with videos related to
Sort By:
Page
of 23
Dermatology Reports
|
April 17, 2025
Acral lentiginous melanoma with subsequent spontaneous vitiligo vulgaris: a case report and literature review
Ronak Saeed Ahmed, Rozhgar Rashid Ali, Dilan S Hiwa, et al.
Journal of Biomolecular Structure & Dynamics
|
March 6, 2025
Evaluation of cannabis-derived anti-inflammatory and analgesic treatment in animals and identification of cannabinoid-based effective inhibition of prostaglandin through computational studies
Hamna Rafiq, Ghulam Fareed, Hafiz Muzzammel Rehman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 3, 2018
Efficacy of Antitoxin Therapy in Treating Patients With Foodborne Botulism: A Systematic Review and Meta-analysis of Cases, 1923-2016
John C O'Horo, Eugene P Harper, Abdelghani El Rafei, et al.
Trials
|
November 3, 2020
Hyperimmune anti-COVID-19 IVIG (C-IVIG) Therapy for Passive Immunization of Severe and Critically Ill COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial
Shaukat Ali, Shobha Luxmi, Fatima Anjum, et al.
Nature Chemistry
|
November 24, 2017
Bicyclic Baird-type aromaticity
Won-Young Cha, Taeyeon Kim, Arindam Ghosh, et al.
International Journal of Molecular Sciences
|
August 12, 2022
The Genome of the Mimosoid Legume <i>Prosopis cineraria</i>, a Desert Tree
Naganeeswaran Sudalaimuthuasari, Rashid Ali, Martin Kottackal, et al.
Medicine
|
June 2, 2023
Knowledge, attitudes, and practices (KAP) during the malaria elimination phase: A household-based cross-sectional survey
Siddig Ibrahim Abdelwahab, Ibrahim M Elhassan, Osama Albasheer, et al.
Trials
|
November 9, 2022
Phase II/III trial of hyperimmune anti-COVID-19 intravenous immunoglobulin (C-IVIG) therapy in severe COVID-19 patients: study protocol for a randomized controlled trial
Shaukat Ali, Elisha Shalim, Farah Farhan, et al.
Eclinicalmedicine
|
June 10, 2021
Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial
Shaukat Ali, Syed Muneeb Uddin, Elisha Shalim, et al.
BMC Endocrine Disorders
|
October 22, 2025
Erectile dysfunction among diabetic patients in Western Uganda: prevalence and associated factors in a multicentre study across three selected clinics
Venance Emmanuel Mswelo, Afizi Kibuuka, Tijjani Salihu Shinkafi, et al.
Page
of 23